Literature DB >> 8241444

Breech presentation.

D P Eller1, J P VanDorsten.   

Abstract

This review covers recent literature relevant to breech presentation. Some have advocated routine elective cesarean delivery of the breech fetus of any gestational age to reduce the alleged increase in perinatal morbidity and mortality associated with breech presentation. This indication for cesarean delivery accounts for approximately 15% of all cesarean deliveries and costs society approximately US$ 1.4 billion per year. As a result of concerns with vaginal breech delivery, external cephalic version in the term fetus has become well accepted. A new scoring system has been developed to predict the success of external cephalic version. Repeated external cephalic version has been shown to be successful. Careful ultrasound continues to be important before the procedure. It has been suggested that magnetic resonance pelvimetry may be a practical alternative in evaluating candidates for breech vaginal delivery. There is still no compelling prospective data supporting cesarean delivery for preterm breech presentation. Legal considerations have prevented many from attempting vaginal breech delivery, even in carefully selected patients.

Entities:  

Mesh:

Year:  1993        PMID: 8241444

Source DB:  PubMed          Journal:  Curr Opin Obstet Gynecol        ISSN: 1040-872X            Impact factor:   1.927


  3 in total

1.  Determining cost savings from attempted cephalic version in an inner city delivering population.

Authors:  E K Adams; P D Mauldin; J G Mauldin; R M Mayberry
Journal:  Health Care Manag Sci       Date:  2000-06

Review 2.  [Characteristics of delivery of the small premature infant].

Authors:  H Schneider; E Berger-Menz; W Hänggi
Journal:  Arch Gynecol Obstet       Date:  1995       Impact factor: 2.344

3.  Coming out ahead: the cost effectiveness of external cephalic version using spinal anesthesia.

Authors:  James A O'Brien; Eli Y Adashi
Journal:  Isr J Health Policy Res       Date:  2014-02-24
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.